Back to Trades
Total Value
$8.8M
Net $8.8M sold
Filing Date
Aug 18, 2025
2 transactions
Sales
$8.8M
2 transactions
Trade Summary
On Aug 14, 2025 through Aug 15, 2025, Shanmugam Muthusamy, HEAD OF R&D, COO-NOVITIUM OPS, Director, sold $8.8M of ANI PHARMACEUTICALS INC (ANIP) across 2 transactions. The filing covers Common Stock and reflects net selling of $8.8M. Reported prices ranged from $87.15 to $89.48. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- ANI PHARMACEUTICALS INC
- Ticker Symbol
- ANIP
- CIK
- 0001023024
Insider Information
- Role
- HEAD OF R&D, COO-NOVITIUM OPS, Director
- Location
- BAUDETTE, MN
Filing Details
- Filing Date
- Aug 18, 2025
- Transaction Date
- Aug 14, 2025
- Accession Number
- 0001870913-25-000006
- Form Type
- 4
- Net Trading Amount
- -$8.8M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Aug 14, 2025 | Common Stock | 47,010 | $89.48 | Sale | $4.2M |
| Aug 15, 2025 | Common Stock | 52,990 | $87.15 | Sale | $4.6M |
Want live alerts when Shanmugam Muthusamy trades again?
Download Insider Trades to track ANIP, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The shares were sold in multiple trades at prices ranging from $88.20 to $90.11. The price reported above reflects the weighted average sales price.
- (F2)The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
- (F3)The shares were sold in multiple trades at prices ranging from $85.44 to $90.00. The price reported above reflects the weighted average sales price.
- (F4)The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.